Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden
JAMA Oncol
.
2017 Oct 1;3(10):1429.
doi: 10.1001/jamaoncol.2016.7092.
Authors
Dirk P Dittmer
1
2
,
Susan E Krown
2
,
Ronald Mitsuyasu
2
3
Affiliations
1
Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
2
AIDS Malignancy Consortium, New York, New York.
3
David Geffen School of Medicine, University of California, Los Angeles.
PMID:
28662221
DOI:
10.1001/jamaoncol.2016.7092
No abstract available
Publication types
Comment
MeSH terms
Global Burden of Disease
Humans
Incidence
Neoplasms*
Quality-Adjusted Life Years
Sarcoma, Kaposi / epidemiology*
Grants and funding
P01 CA019014/CA/NCI NIH HHS/United States
P30 CA016086/CA/NCI NIH HHS/United States
R01 DE018304/DE/NIDCR NIH HHS/United States